NICE Adds Arthritis Drugs To Fast Track Appraisal Pathway
This article was originally published in The Pink Sheet Daily
Executive Summary
Clinical and cost effectiveness of Rituxan, Orencia, Humira, and Arava to be evaluated under single technology appraisal process.